212 related articles for article (PubMed ID: 32846403)
21. Quantitative Metabolomics and Lipoprotein Analysis of PDAC Patients Suggests Serum Marker Categories for Pancreatic Function, Pancreatectomy, Cancer Metabolism, and Systemic Disturbances.
Bae G; Berezhnoy G; Flores A; Cannet C; Schäfer H; Dahlke MH; Michl P; Löffler MW; Königsrainer A; Trautwein C
J Proteome Res; 2024 Apr; 23(4):1249-1262. PubMed ID: 38407039
[TBL] [Abstract][Full Text] [Related]
22. Metabonomic studies of pancreatic cancer response to radiotherapy in a mouse xenograft model using magnetic resonance spectroscopy and principal components analysis.
He XH; Li WT; Gu YJ; Yang BF; Deng HW; Yu YH; Peng WJ
World J Gastroenterol; 2013 Jul; 19(26):4200-8. PubMed ID: 23864784
[TBL] [Abstract][Full Text] [Related]
23. Non-invasively predicting differentiation of pancreatic cancer through comparative serum metabonomic profiling.
Wen S; Zhan B; Feng J; Hu W; Lin X; Bai J; Huang H
BMC Cancer; 2017 Nov; 17(1):708. PubMed ID: 29096620
[TBL] [Abstract][Full Text] [Related]
24. Metabolic changes in rat lens after in vivo exposure to ultraviolet irradiation: measurements by high resolution MAS 1H NMR spectroscopy.
Risa Ø; Saether O; Löfgren S; Söderberg PG; Krane J; Midelfart A
Invest Ophthalmol Vis Sci; 2004 Jun; 45(6):1916-21. PubMed ID: 15161858
[TBL] [Abstract][Full Text] [Related]
25. Metabolomic studies of patient material by high-resolution magic angle spinning nuclear magnetic resonance spectroscopy.
Keun H
Methods Enzymol; 2014; 543():297-313. PubMed ID: 24924139
[TBL] [Abstract][Full Text] [Related]
26. Metabolomics approaches in pancreatic adenocarcinoma: tumor metabolism profiling predicts clinical outcome of patients.
Battini S; Faitot F; Imperiale A; Cicek AE; Heimburger C; Averous G; Bachellier P; Namer IJ
BMC Med; 2017 Mar; 15(1):56. PubMed ID: 28298227
[TBL] [Abstract][Full Text] [Related]
27. Impact of real-time metabolomics in liver transplantation: Graft evaluation and donor-recipient matching.
Faitot F; Besch C; Battini S; Ruhland E; Onea M; Addeo P; Woehl-Jaeglé ML; Ellero B; Bachellier P; Namer IJ
J Hepatol; 2018 Apr; 68(4):699-706. PubMed ID: 29191459
[TBL] [Abstract][Full Text] [Related]
28. High-resolution magic angle spinning 1H NMR spectroscopic studies on intact rat renal cortex and medulla.
Garrod S; Humpfer E; Spraul M; Connor SC; Polley S; Connelly J; Lindon JC; Nicholson JK; Holmes E
Magn Reson Med; 1999 Jun; 41(6):1108-18. PubMed ID: 10371442
[TBL] [Abstract][Full Text] [Related]
29. Characterization of the metabolomic profile of renal cell carcinoma by high resolution magic angle spinning proton magnetic resonance spectroscopy.
Huynh MJ; Gusev A; Palmas F; Vandergrift L; Berker Y; Wu CL; Wu S; Cheng LL; Feldman AS
Urol Oncol; 2023 Nov; 41(11):459.e9-459.e16. PubMed ID: 37863744
[TBL] [Abstract][Full Text] [Related]
30. Biological response in various compartments of the rat lens after in vivo exposure to UVR-B analyzed by HR-MAS 1H NMR spectroscopy.
Tessem MB; Bathen TF; Löfgren S; Saether O; Mody V; Meyer L; Dong X; Söderberg PG; Midelfart A
Invest Ophthalmol Vis Sci; 2006 Dec; 47(12):5404-11. PubMed ID: 17122130
[TBL] [Abstract][Full Text] [Related]
31. Urinary metabolite prognostic biomarker panel for pancreatic ductal adenocarcinomas.
Hipperson L; Hadden WJ; Nahm CB; Gill AJ; Samra JS; Dona A; Mittal A; Sahni S
Biochim Biophys Acta Gen Subj; 2021 Nov; 1865(11):129966. PubMed ID: 34329704
[TBL] [Abstract][Full Text] [Related]
32. Metabolic mapping by use of high-resolution magic angle spinning 1H MR spectroscopy for assessment of apoptosis in cervical carcinomas.
Lyng H; Sitter B; Bathen TF; Jensen LR; Sundfør K; Kristensen GB; Gribbestad IS
BMC Cancer; 2007 Jan; 7():11. PubMed ID: 17233882
[TBL] [Abstract][Full Text] [Related]
33. Quantification of metabolites in breast cancer patients with different clinical prognosis using HR MAS MR spectroscopy.
Sitter B; Bathen TF; Singstad TE; Fjøsne HE; Lundgren S; Halgunset J; Gribbestad IS
NMR Biomed; 2010 May; 23(4):424-31. PubMed ID: 20101607
[TBL] [Abstract][Full Text] [Related]
34. Detection of metabolic alterations in non-tumor gastrointestinal tissue of the Apc(Min/+) mouse by (1)H MAS NMR spectroscopy.
Backshall A; Alferez D; Teichert F; Wilson ID; Wilkinson RW; Goodlad RA; Keun HC
J Proteome Res; 2009 Mar; 8(3):1423-30. PubMed ID: 19159281
[TBL] [Abstract][Full Text] [Related]
35. Metabolomic analysis of endometrial cancer by high-resolution magic angle spinning NMR spectroscopy.
Arda Düz S; Mumcu A; Doğan B; Yılmaz E; İnci Çoşkun E; Sarıdogan E; Tuncay G; Karaer A
Arch Gynecol Obstet; 2022 Dec; 306(6):2155-2166. PubMed ID: 35567635
[TBL] [Abstract][Full Text] [Related]
36. Differentiation of pancreatic neuroendocrine carcinoma from pancreatic ductal adenocarcinoma using magnetic resonance imaging: The value of contrast-enhanced and diffusion weighted imaging.
Guo C; Chen X; Wang Z; Xiao W; Wang Q; Sun K; Zhuge X
Oncotarget; 2017 Jun; 8(26):42962-42973. PubMed ID: 28487490
[TBL] [Abstract][Full Text] [Related]
37. Plasma Metabolome Profiling Identifies Metabolic Subtypes of Pancreatic Ductal Adenocarcinoma.
Mahajan UM; Alnatsha A; Li Q; Oehrle B; Weiss FU; Sendler M; Distler M; Uhl W; Fahlbusch T; Goni E; Beyer G; Chromik A; Bahra M; Klein F; Pilarsky C; Grützmann R; Lerch MM; Lauber K; Christiansen N; Kamlage B; Regel I; Mayerle J
Cells; 2021 Jul; 10(7):. PubMed ID: 34359990
[TBL] [Abstract][Full Text] [Related]
38. Quantitative assessment of neurochemical changes in a rat model of long-term alcohol consumption as detected by in vivo and ex vivo proton nuclear magnetic resonance spectroscopy.
Lee DW; Kim SY; Kim JH; Lee T; Yoo C; Nam YK; Jung JY; Shin HC; Kim HY; Kim DJ; Choe BY
Neurochem Int; 2013 Mar; 62(4):502-9. PubMed ID: 23411411
[TBL] [Abstract][Full Text] [Related]
39. Pancreatic cancer early detection: expanding higher-risk group with clinical and metabolomics parameters.
Urayama S
World J Gastroenterol; 2015 Feb; 21(6):1707-17. PubMed ID: 25684935
[TBL] [Abstract][Full Text] [Related]
40. A quantitative comparison of metabolite signals as detected by in vivo MRS with ex vivo 1H HR-MAS for childhood brain tumours.
Wilson M; Davies NP; Grundy RG; Peet AC
NMR Biomed; 2009 Feb; 22(2):213-9. PubMed ID: 19067434
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
